Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Enzychem Lifesciences, Corp., announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to EC-18 for the treatment of Acute Radiation Syndrome (ARS). The US FDA Orphan Drug Designation program provides incentives to companies that are developing therapies for rare diseases which affect fewer than 200,000…

High Point Clinical Trials Center (HPCTC) has successfully launched its latest clinical study offering in Renal Impairment. The increasing demand from the pharmaceutical industry to understand the pharmacokinetic impact of novel drugs in renally compromised patients has prompted HPCTC to expand its clinical service offering. HPCTC is ideally suited to…

GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, today announced that it will proceed with a Phase 2/3 clinical trial for GC1102 (also known as Hepabig-gene), the company's investigational recombinant hepatitis B immune globulin for preventing the recurrence of hepatitis B virus (HBV) infection following…

RXi Pharmaceuticals Corporation a clinical-stage company developing a new class of RNAi-based therapeutics today announced that it will give an oral presentation highlighting the company's proprietary therapeutic platform at the Immuno-Oncology Frontiers World conference. This exclusive Immuno-oncology (I-O) partnering event provides direct access to decision makers and KOL's working towards…

Today, Ziath announced it will showcase its new, cost-effective 2D barcode rack scanner, the DataPaq™ Mirage, at SLAS2018 (3–7 February 2018, San Diego, CA). This innovative camera-based scanner has a low-profile design enabling it to be easily integrated with robotic liquid handling systems, as well as other laboratory automation solutions.…

Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for rare diseases, announced today Phase 2 LIBERTY study results in pulmonary arterial hypertension (PAH) that demonstrated no improvement overall or in key subgroups for both the primary efficacy endpoint of pulmonary vascular resistance (PVR) and the secondary…

RXi Pharmaceuticals Corporation a clinical-stage company developing a new class of RNAi-based therapeutics outlined its 2018 business strategy during a webcast presentation at the Biotech Showcase conference which brought together over 3,500 life science decision makers and investors from over 50 countries to collaborate and discuss industry trends. "After a…

Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the use of TRISENOX® (arsenic trioxide) injection in combination with tretinoin for the treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or…

Sandoz, a Novartis division and the global leader in biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA), submitted under the 351 (k) pathway, for proposed biosimilar adalimumab to the reference medicine, Humira®*. "When patients are dealing with a chronic…

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today the publication of clinical and pre-clinical results by research collaborators at Rgenix and The Rockefeller University. The results of the collaboration, published in the January 11 online issue of Cell, reveal that the…

loader